Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makito Miyake

Showing results (1-10 of 418) with videos related to

Pageof 42
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2018
Editorial Comment from Dr Miyake to Preclinical orthotopic xenograft model of renal pelvis cancer in which cancer growth could be traced by an in vivo imaging systemMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2024
Editorial Comment from Dr Miyake to Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART)Makito Miyake
Translational Andrology and Urology|June 10, 2024
Combination therapies targeting different aspects of tumor biology for patients with advanced urothelial carcinomaMakito Miyake
Translational Andrology and Urology|May 16, 2025
Current perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladderMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|May 15, 2025
Editorial Comment From Dr. Miyake to Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective StudyMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|April 30, 2026
Editorial Comment to Real-World Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical DatabaseMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 28, 2025
Editorial Comment from Dr Miyake to α1-blockers as a risk factor for hypotension in combination with oral 5-aminolevulimic acid for photodynamic diagnosis in patients with bladder cancerMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 12, 2026
Editorial Comment to "Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)"Makito Miyake
Translational Andrology and Urology|January 12, 2026
Impact of durable response of first-line systemic treatment for patients with locally advanced or metastatic urothelial carcinoma: data update of EV-302/KEYNOTE-A39 trialMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|May 4, 2024
Editorial Comment from Dr Miyake to Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classificationMakito Miyake
Pageof 42

Showing results (1-10 of 418) with videos related to

Sort By:
Pageof 42
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2018
Editorial Comment from Dr Miyake to Preclinical orthotopic xenograft model of renal pelvis cancer in which cancer growth could be traced by an in vivo imaging systemMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2024
Editorial Comment from Dr Miyake to Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART)Makito Miyake
Translational Andrology and Urology|June 10, 2024
Combination therapies targeting different aspects of tumor biology for patients with advanced urothelial carcinomaMakito Miyake
Translational Andrology and Urology|May 16, 2025
Current perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladderMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|May 15, 2025
Editorial Comment From Dr. Miyake to Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective StudyMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|April 30, 2026
Editorial Comment to Real-World Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical DatabaseMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 28, 2025
Editorial Comment from Dr Miyake to α1-blockers as a risk factor for hypotension in combination with oral 5-aminolevulimic acid for photodynamic diagnosis in patients with bladder cancerMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 12, 2026
Editorial Comment to "Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)"Makito Miyake
Translational Andrology and Urology|January 12, 2026
Impact of durable response of first-line systemic treatment for patients with locally advanced or metastatic urothelial carcinoma: data update of EV-302/KEYNOTE-A39 trialMakito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|May 4, 2024
Editorial Comment from Dr Miyake to Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classificationMakito Miyake
Pageof 42